Urology is concerned with pathologies of the urinary tract (bladder, ureter, urethra, kidneys, etc.) in men and women and urogenital pathologies in men (prostate, penis, testicles).
The Urology Department is structured according to a number of areas of expertise:
- The Oncological Urology Clinic straddles the Erasmus Hospital and the Jules Bordet Institute. It provides multidisciplinary treatment for cancers of the bladder, prostate, kidneys, testicles and penis (cf Focus).
- The Prostate Clinic is concerned with non-cancerous pathologies of the prostate (prostatic hypertrophy for example). The treatment proposed (laser, thermotherapy, etc.) aims to maintain a maximum of sexual and urinary functions.
- Functional urology is concerned with problems connected to functions of the urogenital system. In particular, the Incontinence Clinic proposes urodynamic testing and assessment and a full range of treatment depending on the type of incontinence.
- At the Traumatology and Rehabilitation Centre (CTR), neuro-urology consultations are proposed for patients who develop a urological problem following a neurological pathology or accident.
- The Sexual Problems Clinic (erection or ejaculation problems, painful penetration, vaginismus, etc.) proposes multidisciplinary treatment bringing together urologists, sexologists, physiotherapists, etc.
- Urinary stones or lithiasis are diagnosed, treated and prevented, in cooperation with the Nephrology Department.
The Urology Department at the Brussels University Hospital (H.U.B.) has developed particular expertise in treating cancers of the penis. These rare but serious cancers are treated by means of minimally invasive robotic surgery and using the sentinel lymph node procedure. The department proposes an approach that causes the least damage possible as well as reconstructions following partial or complete amputation of the penis.
In fundamental research, the Urology Department, within the Brussels University Hospital (H.U.B.) and the experimental Medicine Laboratory, studies the role of certain enzymes in prostatic pathologies.
The department also participates in clinical studies. One project carried out in cooperation with the Medical Imaging Department is seeking to establish eligibility criteria to avoid unnecessary punctures in (suspected) cases of prostate cancer.
Le Service d’Urologie de l’H.U.B est organisé en plusieurs secteurs de l’adulte :
- Uro-oncologie : prise en charge des cancers des reins, de la vessie, des voies urinaires supérieurs, de la prostate, des testicules et du pénis
- Endourologie : prise en charge des calculs urinaires, obstruction urinaire et autres troubles prostatiques
- Urologie fonctionnelle, chirurgie reconstructrice et troubles du plancher pelvien : prise en charge de l’incontinence, des prolapsus pelviens et autres troubles du plancher pelvien
- Neuro-urologie (Centre de Traumatologie et Réadaptation (CTR)) : prise en charge des troubles urinaires suites à des accidents ou maladies neurologiques
- Andrologie : prise en charge des troubles de la santé reproductive et sexuelle masculine
Our team
Urologues - Prof. T. Roumeguère, (Chef de service) Oncologie - Lithiase urinaire - Chirurgie de la verge - implantologie
- Dr Beirnaert Jeanne, Pathologie du plancher pelvien - Lithiase urinaire - Urologie générale
- Dr Caes Thomas, Endoscopie prostate - Pathologie rénale - Transplantation rénale
- Dr R. Diamand, Chirurgie robotique - Cancers de la prostate, vessie, testicules, verge
- Dr E. Hawaux, Chirurgie oncologique - Endoscopie
- Dr K. Limani, Urologie fonctionnelle, HIGU
- Moyson Julie, Neuro-Urologie, Pédiatrie, Sexologie
- Dr A. Peltier, Chirurgie robotique - Cancers de la prostate - Traitement focal prostate
- Dr T. Quackels, Chirurgie robotique - Cancers de la prostate, rein, vessie, testicules
- Prof. L. Tosco, Chirurgie oncologique
- Prof. T. Roumeguère, (Chef de service) Oncologie - Lithiase urinaire - Chirurgie de la verge - implantologie
- Consultants
- Dr Coscarella Mathieu, Urologie générale
- Dr Sotorres José, Urologie générale
- Dr Svistakov Ilyas, Urologie générale
- Dr Vanden Bossche Marc, Urologie générale
04/11/2024
Publications
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection
- Auteurs : Diamand R, Guenzel K, Mjaess G, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Benijts J, Assenmacher G, Roumeguère T, Peltier A
- Journal : Eur Urol Focus, 2024 Mar 19:S2405-4569(24)00047-6. doi: 10.1016/j.euf.2024.03.003.
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
- Auteurs : Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T
- Journal : Eur Urol Focus, 2023 Mar;9(2):298-302. doi: 10.1016/j.euf.2022.09.011. Epub 2022 Oct 6.
Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study
- Auteurs : Peltier A, van Velthoven R, Baudewyns A, Assenmacher G, Lemort M, Lefebvre Y, Sirtaine N, Diamand R
- Journal : BJU Int, 2024 Aug;134(2):258-267. doi: 10.1111/bju.16385. Epub 2024 May 14.
Retzius-sparing versus standard robot-assisted laparoscopic prostatectomy: A two-year patient-reported and oncological assessment
- Auteurs : Diamand R, Bernard PL, Mjaess G, Benijts J, Assenmacher C, Assenmacher G
- Journal : Prostate. 2024 Oct 9. doi: 10.1002/pros.24807. Online ahead of print.
Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy
- Auteurs : Leplat C, Jabbour T, Diamand R, Baudewyns A, Bourgeno HA, Shagera QA, Flamen P, Roumeguere T, Peltier A, Artigas C
- Journal : Cancers (Basel). 2023 May 26;15(11):2926. doi: 10.3390/cancers15112926.
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer
- Auteurs : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, T'Kint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ
- Journal : Prostate Cancer Prostatic Dis. 2022 Feb;25(2):199-207. doi: 10.1038/s41391-021-00397-2. Epub 2021 Jun 9.
Movember 2024 at the Jules Bordet Institute (H.U.B)
In November, Bordet is pulling out all the stops and proposing a range of activities designed exclusively for men: pétanque, workshops, chat, sound journey, massage and more.